Nanosystems in Cosmetic Products: A Brief Overview of Functional, Market, Regulatory and Safety Concerns.
cosmetics
dermal delivery
nanomaterials
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
05 Sep 2021
05 Sep 2021
Historique:
received:
29
07
2021
revised:
31
08
2021
accepted:
02
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Nanosystems exhibit various innovative physico-chemical properties as well as a range of cosmetic functions, including increased skin retention for loaded compounds. The worldwide nano-market has therefore been consistently extensive in recent decades. This review summarizes the most important properties of nanosystems that are employed in cosmetics, including composition, functions and interactions with skin, with particular attention being paid to marketed products. Moreover, the worldwide regulatory landscape of nanomaterials used as cosmetic ingredients is considered, and the main safety concerns are indicated. In general, advanced physico-chemical characterization is preliminarily needed to assess the safety of nanomaterials for human health and the environment. However, there is currently a shortfall in global legislation as a universally accepted and unambiguous definition of a nanomaterial is still lacking. Therefore, each country follows its own regulations. Anyhow, the main safety concerns arise from the European context, which is the most restrictive. Accordingly, the poor dermal permeation of nanomaterials generally limits their potential toxic effects, which should be mainly ascribed to unwanted or accidental exposure routes.
Identifiants
pubmed: 34575484
pii: pharmaceutics13091408
doi: 10.3390/pharmaceutics13091408
pmc: PMC8470546
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Università degli Studi di Torino
ID : Ricerca Locale 2019
Références
Future Sci OA. 2020 Aug 06;6(10):FSO613
pubmed: 33312696
Recent Pat Biotechnol. 2009;3(2):118-23
pubmed: 19519567
Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S131-55
pubmed: 12460720
Nanomaterials (Basel). 2019 Jan 13;9(1):
pubmed: 30642104
Molecules. 2020 Aug 15;25(16):
pubmed: 32824172
Adv Pharm Bull. 2020 Jun;10(2):150-165
pubmed: 32373485
Nanoscale. 2018 May 17;10(19):8911-8937
pubmed: 29722421
Nanomaterials (Basel). 2020 May 20;10(5):
pubmed: 32443655
Clin Cosmet Investig Dermatol. 2021 Jul 13;14:867-887
pubmed: 34285534
Pharmaceutics. 2014 Feb 28;6(1):52-77
pubmed: 24590260
Nature. 2006 Nov 16;444(7117):267-9
pubmed: 17108940
Daru. 2014 Aug 15;22:59
pubmed: 25123555
Int J Mol Sci. 2020 Sep 02;21(17):
pubmed: 32887477
J Cosmet Dermatol. 2018 Dec;17(6):1073-1083
pubmed: 29226503
ISRN Dermatol. 2014 May 22;2014:843687
pubmed: 24963412
Int J Cosmet Sci. 2008 Feb;30(1):19-33
pubmed: 18377627
Curr Pharm Des. 2013;19(35):6353-66
pubmed: 23469998
J Cosmet Laser Ther. 2016 Jun;18(3):174-81
pubmed: 25968161
Drug Metab Rev. 2020 May;52(2):319-332
pubmed: 32393070
J Cosmet Laser Ther. 2017 Dec;19(8):485-493
pubmed: 28753057
Curr Drug Metab. 2017;18(5):412-425
pubmed: 28266273
Int J Pharm. 2009 Jan 21;366(1-2):170-84
pubmed: 18992314
Food Chem Toxicol. 2017 Nov;109(Pt 1):753-770
pubmed: 28578101
Crit Rev Toxicol. 2007 Mar;37(3):251-77
pubmed: 17453934
Nanomedicine. 2010 Aug;6(4):570-4
pubmed: 20060498
Int J Nanomedicine. 2017 Jul 17;12:5087-5108
pubmed: 28761343
Beilstein J Nanotechnol. 2015 Aug 21;6:1769-80
pubmed: 26425429
Regul Toxicol Pharmacol. 2016 Apr;76:215-6
pubmed: 26776753
Photodermatol Photoimmunol Photomed. 2019 Nov;35(6):442-446
pubmed: 30444533
Toxicol Pathol. 2011 Feb;39(2):301-24
pubmed: 21422259
J Control Release. 2014 Dec 28;196:9-18
pubmed: 25278258
Arch Toxicol. 2014 Dec;88(12):2191-211
pubmed: 25326817
J Control Release. 2010 Feb 15;141(3):277-99
pubmed: 19850095
Regul Toxicol Pharmacol. 2015 Oct;73(1):137-50
pubmed: 26111608
Nanomedicine. 2013 Jan;9(1):1-14
pubmed: 22684017
Int J Cosmet Sci. 2014 Jun;36(3):273-83
pubmed: 24575878
Arch Toxicol. 2015 Dec;89(12):2207-17
pubmed: 26391178
Colloids Surf B Biointerfaces. 2019 Nov 1;183:110416
pubmed: 31398622
Materials (Basel). 2019 Jul 20;12(14):
pubmed: 31330764
J Pharm Bioallied Sci. 2012 Jul;4(3):186-93
pubmed: 22923959
Expert Opin Drug Deliv. 2019 Apr;16(4):313-330
pubmed: 30793641
Regul Toxicol Pharmacol. 2016 Aug;79:103-104
pubmed: 26946407
Front Chem. 2015 Aug 06;3:48
pubmed: 26301216
Eur J Pharm Biopharm. 2019 Nov;144:18-39
pubmed: 31446046
J Clin Dent. 2011;22(5):139-43
pubmed: 22403978
Int J Cosmet Sci. 2020 Feb;42(1):16-28
pubmed: 31724203
Dermatoendocrinol. 2009 Jul;1(4):197-206
pubmed: 20592791
Indian Dermatol Online J. 2013 Oct;4(4):267-72
pubmed: 24350003
J Control Release. 2008 Nov 24;132(1):12-20
pubmed: 18761045
Adv Drug Deliv Rev. 2004 Mar 27;56(5):675-711
pubmed: 15019752
Cutis. 2004 Dec;74(6):362-8
pubmed: 15663072
J Pharm (Cairo). 2018 Mar 27;2018:3420204
pubmed: 29785318
Regul Toxicol Pharmacol. 2016 Feb;74:79-80
pubmed: 26654931
Regul Toxicol Pharmacol. 2018 Oct;98:274-275
pubmed: 30125613
Drug Target Insights. 2007;2:147-57
pubmed: 21901071
Nanomaterials (Basel). 2018 Nov 27;8(12):
pubmed: 30486433
J Eur Acad Dermatol Venereol. 2019 Nov;33 Suppl 7:34-46
pubmed: 31588611
J Control Release. 2017 Feb 10;247:86-105
pubmed: 28024914
Regul Toxicol Pharmacol. 2015 Jul;72(2):310-22
pubmed: 25979643